1. Home
  2. Analysis
  3. Pregabalin
  4. Etravirine

Pregabalin and Etravirine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pregabalin (pregabalin) and Etravirine (etravirine). Common drug interactions include dermatitis atopic among females and drug resistance among males.

The phase IV clinical study analyzes what interactions people have when they take Pregabalin and Etravirine. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

What is Etravirine?

Etravirine has active ingredients of etravirine. eHealthMe is studying from 2,801 Etravirine users. Check the latest studies of Etravirine.

On Jul, 16, 2026

27 people who take Pregabalin and Etravirine together, and have interactions are studied.

Pregabalin and Etravirine drug interactions.

What are the common drug interactions of Pregabalin and Etravirine, by gender? *:

female:

  1. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  2. Dry skin

male:

  1. Drug resistance (reduction in effectiveness of a drug)
  2. Glomerular filtration rate decreased
  3. Surgery
  4. Anaemia (lack of blood)
  5. Hypotension (abnormally low blood pressure)
  6. Oedema (fluid collection in tissue)
  7. Post procedural haemorrhage (post procedural bleeding)
  8. Dyspnoea (difficult or laboured respiration)
  9. Renal failure (kidney dysfunction)
  10. Weight decreased

What are the common drug interactions of Pregabalin and Etravirine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood cholesterol increased
  2. Weight increased
  3. Oedema (fluid collection in tissue)

50-59:

  1. Blood creatine phosphokinase increased
  2. Blood potassium decreased
  3. Drug resistance (reduction in effectiveness of a drug)
  4. Glomerular filtration rate decreased

60+:

  1. Coronary artery occlusion (complete obstruction of blood flow in a coronary artery)
  2. Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
  3. Dyspnoea (difficult or laboured respiration)
  4. Renal failure (kidney dysfunction)
  5. Weight decreased
  6. Left ventricular failure (left ventricle fails to contract forcefully)
  7. Skin ulcer
  8. Surgery
  9. Anaemia (lack of blood)
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Hiv Infection: 23 people, 85.19%
  2. Procedural Pain: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and Etravirine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pregabalin and Etravirine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Etravirine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pregabalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Etravirine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin and etravirine (the active ingredients of Pregabalin and Etravirine, respectively), and Pregabalin and Etravirine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.